CUV.AX

Clinuvel Pharmaceuticals Limited

1CUV
AUS
ASX

$10.30

24H

0.71%

Market Cap

516.4 M

Volume

114.5 K

Supply

501.3 K

Price Chart

About Clinuvel Pharmaceuticals Limited - CUV.AX

Clinuvel Pharmaceuticals Limited is an Australian biopharmaceutical company focused on developing drugs for the treatment of a range of disorders caused by a lack of melanin, particularly the rare disease erythropoietic protoporphyria (EPP). Their most notable product is Scenesse (afamelanotide), a first-in-class drug implant designed to provide photoprotection for adult patients with EPP.

What are Clinuvel Pharmaceuticals Limited's core values and mission statement?

Clinuvel Pharmaceuticals Limited's mission is to develop and deliver treatments that improve the lives of patients with a range of severe skin disorders. Their core values center on innovation, commitment to patients, scientific excellence, and social responsibility to provide long-term health solutions.

Who founded Clinuvel Pharmaceuticals Limited and when?

Clinuvel Pharmaceuticals Limited was founded by Dr. Philippe Wolgen in 1987.

Who leads Clinuvel Pharmaceuticals Limited?

As of the last update available, Dr. Philippe Wolgen served as the CEO of Clinuvel Pharmaceuticals Limited.

Where is Clinuvel Pharmaceuticals Limited located, and what is its base country?

Clinuvel Pharmaceuticals Limited is headquartered in Melbourne, Australia, and Australia is its base country.

On which exchanges is Clinuvel Pharmaceuticals Limited traded?

Clinuvel Pharmaceuticals Limited is traded on the Australian Securities Exchange (ASX) under the ticker symbol CUV and on the OTC market in the United States under the ticker symbol CLVLY.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open/Close
Low/High
Volume
Cap
Show More

Clinuvel Pharmaceuticals Limited (CUV) Price Live Data

The live price of Clinuvel Pharmaceuticals Limited (CUV) is $10.30, with a trading volume of 114,506 in the last 24 hours. Wrapstocks updates the CUV price in real-time. Clinuvel Pharmaceuticals Limited is down -0.71% in the last 24 hours. The company has a live market cap of $516,368,521.50 and a supply of 50,127,300 CUV stocks.

Clinuvel Pharmaceuticals Limited (CUV) is traded on Australia Stock Exchange, and currently, the market is closed; trading will be resumed in 15 hours and 8 minutes.

Exchange
ASX
ASX
Australia Stock Exchange
AUS
Opens in
15 hours and 8 minutes
Working Hours
Sun-Fri, 11:00 PM - 05:00 AM
Timezone
GMT+0
Last Updated
21 Feb 2024 04:56 AM